SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Barnes D, Talenti D, Cammell G, Goormastic M, Farquhar L, Henderson M, Vogt D, et al. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection. Hepatology 1997; 26:853857.MEDLINE
  • 2
    Keiding S, Höckerstedt K, Bjøro K, Bondesen S, Hjortrup A, Isoniemi H, Erichsen C, et al. The nordic multicentre double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients. Transplantation 1997; 63:15911594.MEDLINE
  • 3
    Keiding S, Söderdahl G, Höckerstedt K, Bondesen S, Bjøro K, Isoniemi H, Hjortrup A, et al. Treatmet with ursodeoxycholic acid does not prevent acute rejection after liver transplantation: a prospective randomized, placebo-controlled double-blind nordic multicentre study. J Hepatol 1995; 23:85.
  • 4
    Pageaux GP, Blanc P, Perrigault PF, Navarro F, Fabre JM, Souche B, Domergue J, et al. Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation. J Hepatol 1995; 23:119122.MEDLINE
  • 5
    Barnes D, Talenti D, Cammell G, Goormastic M, Farquhar L, Henderson M, Vogt D, et al. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection. Hepatology 1997; 26:853857.MEDLINE
  • 6
    Pageaux GP, Blanc P, Perrigault PF, Navarro F, Fabre J, Souche B, Domergue J, et al. Failure of ursodeoxychoic acid to prevent acute cellular rejection after liver transplantation. J Hepatol 1995; 23:119122.MEDLINE
  • 7
    Keiding S, Hockerstedt K, Bjoro K, Bondesen S, Hjortrup A, Isoniemi H, Erichsen C, et al. The Nordic multicenter double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients. Transplantation 1997; 63:15911594.MEDLINE